CTI BioPharma waiting $10 million milestone from Teva for FDA approving Trisenox for certain leukemia
CTI BioPharma is expecting $10 million milestone in February, 2018 from Teva, related to a milestone for U.S. Food and…
Pharmaceuticals, Biotechnology and Life Sciences
CTI BioPharma is expecting $10 million milestone in February, 2018 from Teva, related to a milestone for U.S. Food and…
TxCell got an interest-free loan from Bpifrance, a French government agency, for the preclinical development of its most advanced CAR-Treg…
The FDA has set Novartis’s Kymriah suspension injection for patients who have relapsed or refractory diffuse large B-cell lymphona (DLBCL)…
Ipsen and Exelixis on Tuesday said that their phase 3 study of study of cabozantinib in patients with advanced liver…
Midatech Pharma will conduct a study of an investigational new drug for the treatment of the fatal childhood brain cancer…
Israel’s largest drugmaker, and world’s renown generic drug’s leading producer Teva, through it’s USA outpost Teva Ltd, said that that…
Novartises division Sandoz has asked the FDA to review their Biologic License Application for biosimilar adalimumad, related to Humira, for…
INEOS Styrolution, a global styrenics supplier with a focus on styrene monomer, polystyrene, ABS Standard and styrenic specialties, will present…
Boehringer Ingelheim Pharmaceuticals has gotten an approval from the FDA, for a broadened indication of its afatinib for patients with…
Evgen Pharma, a clinical stage drug development company focused on cancer and neurological conditions, will showcase the results of mechanistic…